The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
Osteoporosis affects 1 in 5 men over 50, yet most go unscreened and face worse outcomes than women when fractures occur.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback